Literature DB >> 6250581

Inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopenicillanic acid: kinetics.

M J Loosemore, S A Cohen, R F Pratt.   

Abstract

The kinetics of the inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopenicillanic acid are described. Loss of beta-lactamase activity is accompanied by a decrease in protein fluorescence, by the appearance of a protein-bound chromophore at 326 nm, and by loss of tritium from 6 alpha-[3H]-6 beta-bromopenicillanic acid. It is shown that all of the above changes probably have the same rate-determining step. The inactivation reaction is competitively inhibited by cephalosporin C, a competitive inhibitor of this enzyme, and by covalently bound clavulanic acid, suggesting that 6 beta-bromopenicillanic acid reacts directly with the beta-lactamase active site. It is proposed that this inhibitor reacts initially as a normal substrate and that the rate-determining step of the inactivation is acylation of the enzyme. A rapid irreversible inactivation reaction rather than normal hydrolysis of the acyl-enzyme then follows acylation; 6 beta-bromopenicillanic acid is thus a suicide substrate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6250581     DOI: 10.1021/bi00558a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Inactivation of the thiol RTEM-1 beta-lactamase by 6-beta-bromopenicillanic acid. Identity of the primary active-site nucleophile.

Authors:  A K Knap; R F Pratt
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

2.  Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria.

Authors:  K Bush; J S Freudenberger; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

Review 3.  Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics.

Authors:  H Ogawara
Journal:  Microbiol Rev       Date:  1981-12

4.  Interaction of beta-iodopenicillanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39.

Authors:  J M Frère; C Dormans; C Duyckaerts; J De Graeve
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

5.  Oligonucleotide-directed mutagenesis as a general and powerful method for studies of protein function.

Authors:  G Dalbadie-McFarland; L W Cohen; A D Riggs; C Morin; K Itakura; J H Richards
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

6.  7 alpha-formylamino substituent confers beta-lactamase-inactivating potency on 1-oxacephalosporins.

Authors:  K Murakami; M Doi; T Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

7.  6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization.

Authors:  B A Moore; K W Brammer
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

8.  Structural basis of the inhibition of class A beta-lactamases and penicillin-binding proteins by 6-beta-iodopenicillanate.

Authors:  Eric Sauvage; Astrid Zervosen; Georges Dive; Raphael Herman; Ana Amoroso; Bernard Joris; Eveline Fonzé; Rex F Pratt; André Luxen; Paulette Charlier; Frédéric Kerff
Journal:  J Am Chem Soc       Date:  2009-10-28       Impact factor: 15.419

9.  The Molecular Basis of β-Lactamase Catalysis and Inhibition.

Authors:  A L Fink
Journal:  Pharm Res       Date:  1985-03       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.